Get the Stockscreener App
4.97
1.02%
0.05
After Hours:
4.96
-0.010
-0.20%
Lexeo Therapeutics Inc stock is traded at $4.97, with a volume of 446.73K.
It is up +1.02% in the last 24 hours and up +4.19% over the past month.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
See More
Previous Close:
$4.92
Open:
$4.92
24h Volume:
446.73K
Relative Volume:
0.95
Market Cap:
$268.39M
Revenue:
-
Net Income/Loss:
$-86.60M
P/E Ratio:
-1.7547
EPS:
-2.8324
Net Cash Flow:
$-67.37M
1W Performance:
+4.41%
1M Performance:
+4.19%
6M Performance:
+98.80%
1Y Performance:
-55.62%
1-Day Range:
$4.86
$5.06
1-Week Range:
$4.64
$5.06
52-Week Range:
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
Name
Lexeo Therapeutics Inc
Sector
Industry
Phone
(212) 547-9879
Address
345 PARK AVENUE SOUTH, NEW YORK
Compare LXEO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
4.97 | 258.67M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Initiated | Oppenheimer | Outperform |
| Jun-13-24 | Initiated | Robert W. Baird | Outperform |
| Jun-06-24 | Initiated | H.C. Wainwright | Buy |
| Nov-28-23 | Initiated | Chardan Capital Markets | Buy |
| Nov-28-23 | Initiated | JP Morgan | Overweight |
| Nov-28-23 | Initiated | Leerink Partners | Outperform |
| Nov-28-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-28-23 | Initiated | Stifel | Buy |
View All
Lexeo Therapeutics Inc Stock (LXEO) Latest News
Stifel Maintains Buy Rating on Lexeo Therapeutics (LXEO) - MSN
Visualizing Lexeo Therapeutics Inc. stock with heatmapsJuly 2025 Action & Free Long-Term Investment Growth Plans - Newser
How to manage a losing position in Lexeo Therapeutics Inc.Watch List & Weekly Breakout Stock Alerts - Newser
How to recover losses in Lexeo Therapeutics Inc. stockWeekly Trade Recap & Scalable Portfolio Growth Methods - Newser
What high frequency data says about Lexeo Therapeutics Inc.Quarterly Trade Report & High Win Rate Trade Tips - Newser
Lexeo Therapeutics Inc. stock trend outlook and recovery pathMarket Risk Summary & Proven Capital Preservation Methods - Newser
Real time alert setup for Lexeo Therapeutics Inc. performance2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - Newser
Institutional scanner results for Lexeo Therapeutics Inc.Portfolio Gains Summary & Fast Gain Swing Trade Alerts - Newser
Bear Alert: Is Lexeo Therapeutics Inc. affected by consumer sentimentProduct Launch & Weekly High Momentum Picks - khodrobank.com
Analyzing Lexeo Therapeutics Inc. with multi timeframe charts2025 Year in Review & Free Community Consensus Stock Picks - Newser
Is Lexeo Therapeutics Inc. stock a value trapMarket Trend Review & Growth Focused Stock Pick Reports - khodrobank.com
Lexeo Therapeutics Inc. stock momentum explainedGlobal Markets & AI Forecast for Swing Trade Picks - Newser
How does Lexeo Therapeutics Inc. compare to its peers2025 Performance Recap & Breakout Confirmation Trade Signals - khodrobank.com
How sentiment analysis helps forecast Lexeo Therapeutics Inc.2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Can Lexeo Therapeutics Inc. withstand a market correctionQuarterly Trade Report & Fast Exit and Entry Strategy Plans - khodrobank.com
Historical volatility pattern of Lexeo Therapeutics Inc. visualized2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Identifying reversal signals in Lexeo Therapeutics Inc.Market Volume Summary & Low Drawdown Momentum Trade Ideas - Newser
Can trapped investors hope for a rebound in Lexeo Therapeutics Inc.Weekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Strategies to average down on Lexeo Therapeutics Inc.Earnings Beat & Risk Managed Investment Entry Signals - Newser
Is now the right time to enter Lexeo Therapeutics Inc.Market Risk Report & Fast Exit/Entry Strategy Plans - khodrobank.com
Is Lexeo Therapeutics Inc. currently under institutional pressure2025 Market WrapUp & Precise Swing Trade Entry Alerts - khodrobank.com
Published on: 2025-09-01 15:48:56 - Newser
Can Lexeo Therapeutics Inc. reach all time highs this yearTrade Exit Report & AI Optimized Trade Strategies - khodrobank.com
Why is Lexeo Therapeutics Inc. stock going up2025 Macro Impact & Weekly Return Optimization Plans - khodrobank.com
What’s next for Lexeo Therapeutics Inc. stock priceJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser
Should value investors consider Lexeo Therapeutics Inc.2025 Stock Rankings & Momentum Based Trading Ideas - khodrobank.com
What data driven models say about Lexeo Therapeutics Inc.’s futureWeekly Volume Report & Short-Term High Return Strategies - Newser
Technical Charts Suggest Momentum Shift in Lexeo Therapeutics Inc.2025 Price Action Summary & Weekly Momentum Stock Picks - beatles.ru
How to interpret RSI for Lexeo Therapeutics Inc. stockOil Prices & High Return Trade Opportunity Guides - Newser
Price momentum metrics for Lexeo Therapeutics Inc. explainedJuly 2025 Trends & Stock Portfolio Risk Management - Newser
Published on: 2025-08-31 15:36:57 - Newser
Using R and stats models for Lexeo Therapeutics Inc. forecasting2025 Earnings Surprises & Verified High Yield Trade Plans - Newser
Lexeo Therapeutics Inc. Charts Flash Early Recovery Signals getLinesFromResByArray error: size == 0 - 클래시안
Is Lexeo Therapeutics Inc. affected by consumer sentimentEarnings Miss & Technical Analysis for Trade Confirmation - kpenews.com
Published on: 2025-08-30 19:02:33 - Newser
Lexeo Therapeutics Inc Stock (LXEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lexeo Therapeutics Inc Stock (LXEO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Robertson Jenny | Chief Legal Officer |
Aug 18 '25 |
Sale |
4.67 |
542 |
2,530 |
62,556 |
| Adler Eric | Chief Medical Officer |
Aug 18 '25 |
Sale |
4.67 |
608 |
2,838 |
67,073 |
| Townsend Richard Nolan | Chief Executive Officer |
Aug 18 '25 |
Sale |
4.67 |
2,735 |
12,767 |
220,058 |
| See Tai Sandi | Chief Development Officer |
Aug 18 '25 |
Sale |
4.67 |
382 |
1,783 |
58,860 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):